Comparison of short-term DAPT and long-term ... - Research Square

BACKGROUND: The appropriate duration of dual antiplatelet therapy (DAPT) and risk-benefit ratio for long-term DAPT in patients with left main (LM) disease ...







Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug ...
x The MASTER DAPT trial investigated an abbreviated (1 month) versus nonabbreviated. (3í12 month) dual antiplatelet therapy (DAPT) and a ...
P2Y12 Receptor Inhibitors After Percutaneous Coronary Syndromes
post-PCI treatment, especially Dual Antiplatelet Therapy (DAPT), still caused many patients to prematurely discontinue ... with intermediate-term DAPT (6?12 ...
A Meta-Analysis of - IMR Press
in percutaneous coronary intervention (PCI) patients treated with dual antiplatelet therapy (DAPT). We aimed to assess the performance of these RSs for ...



Autres Cours:

Optimal duration of dual antiplatelet therapy after percutaneous ...